[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to "paperless"].

Mise en place de la dématérialisation du dossier patient dans un contexte de COVID dans les services de radiothérapie de l’ONCORAD : passage « au sans papier ».
AURA® report COVID-19 virus Dematerialization Dossiers patients Démarche qualité Dématérialisation Patient files Quality approach Rapport AURA® Virus COVID-19

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 31 05 2021
accepted: 05 06 2021
pubmed: 4 7 2021
medline: 1 10 2021
entrez: 3 7 2021
Statut: ppublish

Résumé

Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.

Identifiants

pubmed: 34215522
pii: S1278-3218(21)00102-5
doi: 10.1016/j.canrad.2021.06.005
pmc: PMC8239946
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

645-647

Informations de copyright

Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

C Boutry (C)

SCM oncologie, département de physique, clinique du Pont-des-Chaumes, 330, avenue Marcel-Unal, 82000 Montauban, France. Electronic address: c_boutry@yahoo.fr.

A Sors (A)

SCM oncologie, département de physique, clinique du Pont-des-Chaumes, 330, avenue Marcel-Unal, 82000 Montauban, France.

K Meynard (K)

SCM oncologie, département de physique, clinique du Pont-des-Chaumes, 330, avenue Marcel-Unal, 82000 Montauban, France; Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France.

M D Zarate (MD)

Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France.

M S Couderc (MS)

Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France.

M V Delmas (MV)

Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France.

P Dudouet (P)

Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH